{"data":[{"accessionNo":"0002100119-26-001017","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0000872589","issuerName":"Regeneron Pharmaceuticals Inc","ticker":"REGN","cusip":"75886F107","securityClass":"Common Stock","eventDate":"2026-03-31","reportingPerson":"Vanguard Capital Management","reportingCik":null,"personType":"IA","sharesOwned":7660810,"percentOfClass":7.37,"filedAt":"2026-04-30"},{"accessionNo":"0000102909-26-002187","formType":"SCHEDULE 13G/A","amendmentNo":7,"issuerCik":"0000872589","issuerName":"Regeneron Pharmaceuticals Inc","ticker":"REGN","cusip":"75886F107","securityClass":"Common Stock","eventDate":"2026-03-13","reportingPerson":"The Vanguard Group","reportingCik":null,"personType":"IA","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-03-27"}],"updatedAt":"2026-09-14T16:58:45.461Z","source":"xoomar.com","docs":"https://xoomar.com/markets/api","license":"https://xoomar.com/terms","attribution":"Credit XOOMAR with a link to the dataset page on xoomar.com when you republish this data"}